tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Defence Therapeutics Announces $4.2M Private Placement

Story Highlights
Defence Therapeutics Announces $4.2M Private Placement

Defence Therapeutics (TSE:DTC) has released an update.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Defence Therapeutics Inc., a Canadian biopharmaceutical company, has announced a private placement of up to $4.2 million to support its preclinical and clinical programs. The offering consists of seven million units, each comprising a common share and a warrant, aimed at advancing the company’s innovative radiopharmaceutical and ADC products.

For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1